These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 14264176)
1. CENTRAL MECHANISMS IN HEADACHE. DALESSIO DJ Headache; 1965 Jan; 5():276-8. PubMed ID: 14264176 [No Abstract] [Full Text] [Related]
2. Prophylaxis of frequent vascular headache with methysergide. HALE AR; REED AF Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795 [No Abstract] [Full Text] [Related]
3. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type. DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415 [No Abstract] [Full Text] [Related]
4. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type. DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198 [No Abstract] [Full Text] [Related]
5. Appraisal of methysergide in treatment of vascular headaches of migraine type. FRIEDMAN AP; ELKIND AH JAMA; 1963 Apr; 184():125-8. PubMed ID: 13959785 [No Abstract] [Full Text] [Related]
6. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY. CROWTHER DL Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849 [No Abstract] [Full Text] [Related]
7. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide). FRIEDMAN AP; LOSIN S Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987 [No Abstract] [Full Text] [Related]
12. CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT). ABBOTT KH Headache; 1965 Jan; 5():261-71. PubMed ID: 14264174 [No Abstract] [Full Text] [Related]
13. [TREATMENT OF MIGRAINE AND ERYTHROPROSOPALGIA WITH METHYSERGIDE]. HEYCK H Munch Med Wochenschr; 1964 Nov; 106():2213-9. PubMed ID: 14315954 [No Abstract] [Full Text] [Related]
14. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania]. REBUCCI GG; COCCAGNA G Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457 [No Abstract] [Full Text] [Related]
15. An evaluation of methysergide in the prevention of migraine and other vascular headaches. LANCE JW; FINE RD; CURRAN DA Med J Aust; 1963 Jun; 50(1)():814-8. PubMed ID: 13928400 [No Abstract] [Full Text] [Related]
16. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491. DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199 [No Abstract] [Full Text] [Related]
17. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES. SICUTERI F Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164 [No Abstract] [Full Text] [Related]
18. USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE. LOVSHIN LL Headache; 1963 Oct; 3():107-11. PubMed ID: 14094106 [No Abstract] [Full Text] [Related]
19. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches. LEIGH WE S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429 [No Abstract] [Full Text] [Related]
20. FATAL INFARCTION OF THE BRAIN IN MIGRAINE. GUEST IA; WOOLF AL Br Med J; 1964 Jan; 1(5377):225-6. PubMed ID: 14074182 [No Abstract] [Full Text] [Related] [Next] [New Search]